ALKBH5 and Other metabolic disease: By integrating mechanistic discovery with translational strategy, our findings lay the groundwork for developing ALKBH5‐based diagnostics and therapies, with broader implications for RNA methylation‐targeted interventions in neurodegenerative and metabolic diseases.